Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2005 | 03-2004 | 03-2003 | 03-2002 | 03-2001 | |
| Sales | 302 | 258 | 630 | 1,198 | 95 |
| Gross Profit | 302 | 258 | 630 | 1,198 | 95 |
| Operating Expenses | 5,215 | 4,958 | 4,183 | 2,640 | 2,447 |
| Operating Income | -4,913 | -4,700 | -3,552 | -1,442 | -2,351 |
| Interest Expense | 230 | 212 | 228 | 220 | 227 |
| Other Income | -763 | -1,602 | -281 | -110 | -11,750 |
| Pre-tax Income | -5,906 | -6,513 | -4,061 | -1,772 | -14,329 |
| Income Tax | 1 | 1 | 0 | 2 | -364 |
| Net Income Continuous | -5,907 | -6,514 | -4,061 | -1,775 | -13,965 |
| Net Income | $-5,907 | $-6,514 | $-4,061 | $-1,775 | $-13,965 |
| EPS Basic Total Ops | -0.47 | -0.58 | -0.40 | -0.19 | -1.53 |
| EPS Basic Continuous Ops | -0.46 | -0.58 | -0.40 | -0.19 | -1.53 |
| EPS Diluted Total Ops | -0.47 | -0.58 | -0.40 | -0.19 | -1.53 |
| EPS Diluted Continuous Ops | -0.46 | -0.58 | -0.40 | -0.19 | -1.53 |
| EBITDA(a) | $-4,557 | $-4,367 | $-3,241 | $-1,175 | $-2,157 |